Pentoxifylline does not act via adenosine receptors in the inhibition of the superoxide anion production of human polymorphonuclear leukocytes
- 15 October 1991
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 180 (1), 53-58
- https://doi.org/10.1016/s0006-291x(05)81253-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Evaluation of combined effects in dose-response wstudies by statistical comparison with additive and independent interactionsJournal of Pharmacological Methods, 1990
- Adenosine and related compounds counteract tumor necrosis factor-alpha inhibition of neutrophil migration: implication of a novel cyclic AMP-independent action on the cell surface.The Journal of Immunology, 1990
- Pentoxifylline modulation of plasma membrane functions in human polymorphonuclear leukocytesInfection and Immunity, 1989
- Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifyllineInfection and Immunity, 1988
- Adenosine promotes neutrophil chemotaxis.The Journal of Experimental Medicine, 1988
- Polymorphonuclear Leukocyte Inhibition by Therapeutic Concentrations of Theophylline Is Mediated by Cyclic-3?, 5?-Adenosine MonophosphateAmerican Review of Respiratory Disease, 1988
- Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils.The Journal of Immunology, 1985
- The role of myeloperoxidase and superoxide anion in the luminol- and lucigenin-dependent chemiluminescence of human neutrophilsMicrochemical Journal, 1984
- Alkylxanthines: Inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activityLife Sciences, 1979